hough hearing loss drug

Oblato Biotech Company Acquires Hearing Loss Drug Discovered by Hough Ear Institute Scientists

OKLAHOMA CITY, OKLAHOMA — Hough Ear Institute (HEI), a nonprofit based in Oklahoma City, has annoucned that its pharmaceutical partner, Auditus LLC, a wholly owned subsidiary of Otologic Pharmaceutics Inc. (OPI), has entered into an agreement with Oblato Inc. Oblato assumes exclusive rights to a drug known as NHPN-1010 to advance clinical research aimed at preserving and…

Read More